|
|
| MRD / Regn No. |
: 20200000803 |
Date |
: 16/06/2026 |
| Patient Name |
: Saravanan Arumugam |
Age & Gender |
: 46 Yrs. / Male |
| Contact No. |
: 9600087439 |
UHID |
: |
| Ht / Wt / BMI |
: 167.5 / 73.1 / 26.05 |
BP S / BP D |
: 122 / 83 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (01/Jan/2018) | ADHESIVE CAPSULITIS (04/Dec/2020) | |
|
Subjective |
: |
LOST TO FOLLOW UP |
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM UNCONTROLLED |
|
Plan |
: |
CONTINUE SEMAGLUTIDE 0.25 MG ,SEE ME IN 1 MONTH WITH FBS 2HPP |
|
| Salient Investigations |
: |
GLYCOSYLATED HEMOGLOBIN (HBA1C): 8.0 % | ESTIMATEDAVERAGE GLUCOSE (EAG): 183 mg/dl | GLYCOSYLATED HEMOGLOBIN (HBA1C): 8.0 % | ESTIMATEDAVERAGE GLUCOSE (EAG): 183 mg/dl | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
ROSUVASTATIN 10 MG
ROSEDAY 10 MG |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE FATIGUE AND MUSCLE PAIN | |
|
2 |
INJECTION SEMAGLUTIDE 0,25 MG
OBEDA
Medicine For DIABETES HEART AND KIDNEY PROTECTION |
SQ |
ONCE A WEEK |
SUBCUTANEOUS
|
|
| MAY CAUSE NAUSEA VOMITING | |
|
3 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 16/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
